Document Detail

The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36.
MedLine Citation:
PMID:  19723907     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: We studied patients with systemic lupus erythematosus (SLE) in 1 clinical practice, and patients enrolled in the 1000 Canadian Faces of Lupus database, to determine the minimally important difference (MID) for pain, fatigue, sleep, Health Assessment Questionnaire-Disability Index (HAQ-DI), and Medical Outcomes Study Short Form-36 (SF-36) Physical Component Score (PCS) and SF-36 Mental Component Score (MCS) using a patient-reported overall health status anchor. METHODS: Patients with SLE who had 2 consecutive clinic visits and completed a HAQ-DI and a pain, fatigue, and sleep visual analog scale (VAS) (0-100), and an overall health status question: "How would you describe your overall status since your last visit?": much better, better, the same, worse, or much worse were included. Those who self-rated as better or worse were considered the "minimally changed" subgroups. Patients with 2 consecutive annual visits in the 1000 Canadian Faces of Lupus database who completed the SF-36 and health transition question were eligible. RESULTS: There were 202 patients in London, Ontario (94% women, mean age 50 yrs, mean disease duration 10 yrs). MID for better and worse on a VAS (0-100) were: pain (-15.8, 8.5), fatigue (-13.9, 9.1), and sleep problems (-8.6, 7.6). The MID for HAQ-DI (scale 0 to 3) was -0.08 (better) and 0.14 (worse). The MID for SF-36 was 2.1 (better) and -2.2 (worse) for the PCS and 2.4 (better) and -1.2 (worse) in the MCS. CONCLUSION: The MID in patients with SLE may be different bidirectionally depending on the measured outcome. The mean change observed for those reporting better than worse outcome in pain and fatigue was greater for better versus worst, in contrast to the HAQ, where the mean change was greater for worsening.
Kim J Colangelo; Janet E Pope; Christine Peschken
Related Documents :
9260447 - The relationship of antiphospholipid antibodies to cognitive function in patients with ...
6966547 - Studies of lymphocytotoxins in infectious mononucleosis: reduced lymphocyte killing in ...
21621947 - Asthma disease management-australian pharmacists' interventions improve patients' asthm...
6203307 - Silent lupus nephritis among patients with discoid lupus erythematosus.
11393497 - Incidence of physician-diagnosed primary sjögren syndrome in residents of olmsted coun...
3224607 - Myoma uterus as a marker of oncogynecological pathology in pre- and post-menopause.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-09-01
Journal Detail:
Title:  The Journal of rheumatology     Volume:  36     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-10-12     Completed Date:  2010-02-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  2231-7     Citation Subset:  IM    
Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cohort Studies
Disability Evaluation*
Fatigue / physiopathology,  psychology
Health Status Indicators
Lupus Erythematosus, Systemic / physiopathology*,  psychology*
Middle Aged
Outcome Assessment (Health Care) / methods*
Pain Measurement
Self Disclosure*
Severity of Illness Index*
Sleep / physiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disea...
Next Document:  Association of alcohol intake and smoking with malignant lymphoma risk in Japanese: a hospital-based...